GeneTex

  • Country / Location Selection

United States (US)

Cancer Tissue Gallery- GTX04423

INSM1 antibody [MSVA-456R] HistoMAX

 

Go to Normal Tissue Gallery Go back to product page Go to HistoMAX page

 

Adrenal gland – INSM1 negative adrenocortical adenoma.
Adrenal gland – INSM1 negative adrenocortical carcinoma.
Adrenal gland – Pheochromocytoma showing moderate to strong INSM1 immunostaining in tumor cells.
Colon – Colorectal adenocarcinoma showing moderate to strong INSM1 immunostaining in a fraction of cells (30-50%).
Esophagus – INSM1 negative adenocarcinoma.
Esophagus – Squamous cell carcinoma showing weak INSM1 immunostaining in a small fraction of cells (<5%).
Ileum – Neuroendocrine tumor showing moderate INSM1 immunostaining in tumor cells.
Kidney – INSM1 negative clear cell renal cell carcinoma.
Kidney – INSM1 negative papillary renal cell carcinoma.
Larynx – INSM1 negative squamous cell carcinoma.
Liver – INSM1 negative cholangiocellular carcinoma.
Liver – INSM1 negative hepatocellular carcinoma.
Lung – INSM1 negative adenocarcinoma.
Lung – Neuroendocrine tumor with strong INSM1 positivity of tumor cells.
Lung – Small cell neuroendocrine carcinoma showing strong INSM1 immunostaining in most tumor cells.
Lung – Small cell neuroendocrine carcinoma showing strong INSM1 immunostaining in most tumor cells.
Ovary – Endomeroid carcinoma showing a weak to moderate INSM1 immunostaining in tumor cells.
Pancreas – INSM1 negative acinar cell carcinoma.
Pancreas – Neuroendocrine tumor showing strong INSM1 immunostaining in tumor cells.
Pharynx – Squamous cell carcinoma showing moderate INSM1 immunostaining in a fraction of tumor cells (20-30%).
Pharynx – Squamous cell carcinoma showing moderate to strong INSM1 immunostaining in a fraction of tumor cells (30-50%).
Prostate – INSM1 negative adenocarcinoma (Gleason 3+3=6).
Prostate – Small cell neuroendocrine carcinoma exhibiting strong INSM1 immunostaining in tumor cells.
Salivary gland – INSM1 negative pleomorphic adenoma.
Skin – INSM1 negative malignant melanoma.
Skin – Merkel cell carcinoma with strong INSM1 positivity of tumor cells.
Stomach – INSM1 negative gastric adenocarcinoma.
Stomach – INSM1 negative gastrointestinal stromal tumor (GIST).
Testis – INSM1 negative seminoma.
Thymus – INSM1 negative thymoma containing some residual INSM1 positive thymic epithelial cells.
Thyroid – INSM1 negative papillary carcinoma.
Thyroid – Medullary carcinoma showing moderate to strong INSM1 immunostaining. Adjacent normal thyroid follicles are INSM1 negative.
Urinary bladder – INSM1 negative muscle-invasive urothelial carcinoma.
Urinary bladder – Small cell neuroendocrine carcinoma exhibiting strong INSM1 positivity in tumor cells.
Uterus – INSM1 negative endometroid carcinoma of the endometrium.
 

| TOP |